Influenza Prophylaxis in the Long-Term Care Facility: A Case-Control Study of the Risk Factors for Adverse Drug Reactions to Amantadine

Current Therapeutic Research - Clinical and Experimental

Volumn 64, Issue 9, 2003, Pages 753-763

  Dolamore, Michael J ^a  

^a Ten Broeck Commons   (United States)

Author keywords

Adverse drug reaction; Amantadine; Influenza A; Long term care facility; Nursing home

Indexed keywords

AMANTADINE; BENZODIAZEPINE; CARBIDOPA PLUS LEVODOPA; CREATINE; CREATININE; GABAPENTIN; NARCOTIC AGENT; NEUROLEPTIC AGENT; PHENYTOIN; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UREA; VALPROIC ACID;

AGED; ARTICLE; CLINICAL ARTICLE; CONFUSION; CONTROLLED STUDY; DELUSION; DEMENTIA; DRUG TOLERABILITY; FEMALE; HALLUCINATION; HIGH RISK POPULATION; HUMAN; INFLUENZA VIRUS A; KIDNEY DISEASE; KIDNEY FUNCTION; LOW DRUG DOSE; MALE; NURSING HOME; PRIORITY JOURNAL; PROPHYLAXIS; SIDE EFFECT; STATISTICAL ANALYSIS; UREA NITROGEN BLOOD LEVEL;

EID: 1642479984     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.curtheres.2003.11.001     Document Type: Article

References (18)

1. McLure KL. Economic impact of influenza in LTCF. Presented at the 29th American Society of Consultant Pharmacists Annual Meeting; Seattle, Wash; November 11-14, 1999.
2. Campbell G, Graham-Robinson N. Amantadine for influenza. Choosing the correct dosage for elderly patients. Pharmacy Connects. 1999;1-7. Available at: http://members. pharmacyconnects.com/content/phpractice/1999/01-99/php019905. html. Accessed October 27, 2003.
3. Kingston BJ, Wright CV Jr. Influenza in the nursing home. Am Fam Physician. 2002; 65:75-78.
4. McLure KL. Influenza management: Prevention, prophylaxis and treatment. Presented at the 29th American Society of Consultant Pharmacists Annual Meeting; Seattle, Wash; November 11-14, 1999.
5. AGS Position Statement. Prevention and treatment of influenza in the elderly. September 1996. Updated 1999. Available at: http://www. americangeriatrics.org/products/ positionpapers/influe96.html. Accessed October 27, 2003.
6. Tamblyn SE. Amantadine use in influenza outbreaks in long-term care facilities. CMAJ. 1997;157:1573-1576.
7. Drinka PJ, Gravenstein S, Schilling M, et al. Duration of antiviral prophylaxis during nursing home outbreaks of influenza A: A comparison of 2 protocols. Arch Intern Med. 1998;158:2155-2159.
8. Gomolin IH, Kathpalia RK. Influenza. How to prevent and control nursing home outbreaks. Geriatrics. 2002;57:28-30, 33-34.
9. Keyser LA, Karl M, Nofziger AN, Bertino JS Jr. Comparison of central nervous system adverse effects of amantadine and rimantadine used as sequential prophylaxis of influenza A in elderly nursing home patients. Arch Intern Med. 2000;160:1485-1488.
10. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2000;49(RR03):1-38. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/ rr4903a1.htm. Accessed October 27, 2003.
11. Macchio GJ, Ito V, Sahgal V. Amantadine-induced coma. Arch Phys Med Rehabil. 1993; 74:1119-1120.
12. Papaioannou A, Clarke JA, Campbell G, Bédard M. Assessment of adherence to renal dosing guidelines in long-term care facilities. J Am Geriatr Soc. 2000;48:1470-1473.
13. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.
14. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12: 189-198.
15. Bobby B, Sitar DS. The effect of lactate on sex differences in rat renal tubular energy-dependent transport of the organic cation amantadine. Pharmacology. 2001;62: 188-192.
16. Goralski KB, Smyth DD, Sitar DS. In vivo analysis of amantadine renal clearance in the uninephrectomized rat: Functional significance of in vitro bicarbonate-dependent amantadine renal tubule transport. J Pharmacol Exp Ther. 1999;290:496-504.
17. Bowles SK, Kennie N, Ruston L, et al. Influenza outbreak in a long-term care facility: Considerations for pharmacy. Am J Health Syst Pharm. 1999;56:2303-2307.
18. Amantadine. In: USP DI. Drug Information for the Health Care Provider. Rockville, Md: 1999:1-13.